United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 1997_register executive 2010-09-24 article Part IV Notices D09002ee1be00c5d2 D09002ee1be00c673 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled ``Guidance for FDA and Industry: Direct Final Rule Procedures.'' This guidance explains when and how FDA will employ direct final rulemaking. FDA believes that direct final rulemaking will expedite the issuance of routine or otherwise noncontroversial rules and conserve limited Government resources for carrying out the agency' regulatory functions. 62 FR 62466 https://www.govinfo.gov/app/details/FR-1997-11-21/97-30704 97-30704 fr21no97-154 4160-01-F Docket No. 97D-0439 https://www.govinfo.gov/app/details/FR-1997-11-21/97-30704 https://www.govinfo.gov/content/pkg/FR-1997-11-21/html/97-30704.htm https://www.govinfo.gov/content/pkg/FR-1997-11-21/pdf/97-30704.pdf 5 p. 62466 62470 62 FR 62466 Guidance for FDA and Industry: Direct Final Rule Procedures; Federal Register Vol. 62, Issue NOTICE 97-30704 IV DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No. 97D-0439 4160-01-F 97-30704 Notice.

The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled ``Guidance for FDA and Industry: Direct Final Rule Procedures.'' This guidance explains when and how FDA will employ direct final rulemaking. FDA believes that direct final rulemaking will expedite the issuance of routine or otherwise noncontroversial rules and conserve limited Government resources for carrying out the agency' regulatory functions.

Written comments may be submitted at any time. Marquita B. Steadman, Office of Policy (HF-26), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-3480. Vol. 62, no. 225 Office of the Federal Register, National Archives and Records Administration 1997-11-21 continuing daily deposited born digital 267 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-1997-11-21 P0b002ee180a43425 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr21no97 https://www.govinfo.gov/app/details/FR-1997-11-21 https://www.govinfo.gov/content/pkg/FR-1997-11-21/pdf/FR-1997-11-21.pdf fdlp 62239 62494 DGPO 2010-09-24 2023-05-06 FR-1997-11-21 machine generated eng FR FR-1997-11-21 62 225